Medical professionals and executives from the pharma, biotech, and medical device community, are invited to attend the 3rd Aligning Drug Safety Functions & REMS Summit being live-streamed on September 12-13, 2022. The theme of the summit is to help professionals to assess and track risk management processes and functions across all safety departments in the medical arena.
The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company is well known for hosting well-curated conferences where executives and industry leaders from different health niches can discuss ways of improving and streamlining medical, health, and drug-related procedures and standards.
The virtual DGE summit will be attended by eminent industry leaders who will share keynotes and host panel discussions on important topics of the summit. The conference will be a learning experience for participants where they will get valuable tips and suggestions from speakers for effective strategies and minimizing risk.
The summit offers detailed discussions on effective communication with safety teams, selecting and cooperating with vendors, and coping with technological and regulatory changes that impact risk management and pharmacovigilance. The COVID-19 pandemic has created numerous hardships. Regulatory authorities have provided new guidelines during the pandemic that has the potential to impact ongoing regulatory expectations.
Top reasons to attend:
- Hear Progressive Cross-Functional Work streams Across the Product’s Lifecycle- A New Era of Safety
- Determine Global Risk Management Strategy and REMS
- Effective Ways to Build and Communicate with Safety and Risk Teams
- Discuss the regulatory concerns and patient safety with sponsors and vendors
- Learn the new technologies and communicate with vendors effectively
- Understand vendor selection strategies and oversight methodologies
- Ensure the safety of patients and HCPs with appropriate drug information
The conference will commence with opening remarks from the chairperson, moving on to discuss the key challenges and impacts across the three vital subject pillars: people, process, and technology. Attendees will get clear insights on how to ensure REMS program launch success. In addition, post-marketing assessment of medicines plays a key role for better defining drug safety profiles in real-world settings. Learn the strategies that optimize cross-functional Risk Management, Pharmacovigilance, and REMS Teams.
To learn more, please visit https://nnw.fm/crhag.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
No comments:
Post a Comment